ArticleNaunyn-Schmiedeberg's archives of pharmacology2006

Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung.

Yoshiyuki Tanabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.